Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC
Clinical trial NCT03616691 · UNKNOWN
Trial details
- NCT number
- NCT03616691
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2020-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.